Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Nuchev Pty Ltd ( (AU:NUC) ) has provided an update.
Nuchev Limited has appointed Meng Zhang, known as Leo, as a Non-Executive Director to its Board. Leo Zhang brings over a decade of cross-border experience in brand management, international trade, and corporate governance, with a strong background in the Asia-Pacific consumer goods market. His leadership at H&S Global Brand Center has been instrumental in the success of several brands in China’s cross-border e-commerce sector and Southeast Asia. This appointment is expected to enhance Nuchev’s board skills and experience, supporting the company’s growth ambitions and recent strategic initiatives, including the acquisition of the bWellness business and partnerships with Brauer and H&S Brands.
The most recent analyst rating on (AU:NUC) stock is a Hold with a A$0.14 price target. To see the full list of analyst forecasts on Nuchev Pty Ltd stock, see the AU:NUC Stock Forecast page.
More about Nuchev Pty Ltd
Nuchev is an Australian-based nutritional and wellness business. The company offers products under brands such as Oli6®, Bio Practica, and Medicine Tree, along with several globally recognized European brands sold under exclusive license in Australia and New Zealand by bWellness. Their products are available in key Australian pharmacy and grocery channels, as well as in China and other overseas markets through online and general trade retail. Nuchev is committed to sourcing world-class ingredients and manufacturing under industry-leading Australian facilities to ensure high-quality products for consumers.
Average Trading Volume: 29,979
Technical Sentiment Signal: Buy
Current Market Cap: A$27.8M
Find detailed analytics on NUC stock on TipRanks’ Stock Analysis page.